Lexaria notes FDA approval of Eli Lilly's oral weight-loss drug Foundayo

Go back to Lexaria notes FDA approval of Eli Lilly's oral weight-loss drug Foundayo
(NASDAQ: LEXX) Delayed: 0.56 -0.01 (1.75%)
Previous Close $0.57    52 Week High
Open $0.55    52 Week Low
Day High $0.58    P/E N/A 
Day Low $0.54    EPS
Volume 50,748